Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: the CHEMIST pilot RCT›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: the CHEMIST pilot RCT · References

References

CC BY 4.0 · NIHR Journals Library · approximately 11 min read

  1. World Health Organization (WHO). The Global Burden of Disease: 2004 Update. Geneva: WHO; 2008.
  2. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long Term Conditions and Mental Health: The Cost of Co-morbidities. London: The King’s Fund and Centre for Mental Health; 2012.
  3. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851–8. 10.1016/S0140-6736(07)61415-917826170
  4. Mercer SW, Watt GC. The inverse care law: clinical primary care encounters in deprived and affluent areas of Scotland. Ann Fam Med 2007;5:503–10. 10.1370/afm.77818025487
  5. Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J. Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res 2015;24:909–18. 10.1007/s11136-014-0820-725344816
  6. NHS England and Public Health England. Five Year Forward View. URL: www.england.nhs.uk/ourwork/futurenhs/5yfv-fore/ (accessed 30 October 2019).
  7. Naylor C, Das P, Ross S, Honeyman M, Thompson J, Gilburt H. Bringing Together Physical and Mental Health. London: The King’s Fund and Centre for Mental Health; 2016.
  8. NHS. The NHS Long Term Plan. URL: www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf (accessed 30 October 2019).
  9. Cuijpers P, de Graaf R, van Dorsselaer S. Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J Affect Disord 2004;79:71–9. 10.1016/S0165-0327(02)00348-815023482
  10. National Collaborating Centre for Mental Health, National Institute for Health Clinical Excellence, British Psychological Society, Royal College of Psychiatrists. Common Mental Health Disorders: Identification and Pathways to Care. London: RCPsych Publications; 2011.
  11. Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both. Br J Psychiatry 2013;202:22–7. 10.1192/bjp.bp.112.11216923284149
  12. Rodríguez MR, Nuevo R, Chatterji S, Ayuso-Mateos JL. Definitions and factors associated with subthreshold depressive conditions: a systematic review. BMC Psychiatry 2012;12:181. 10.1186/1471-244X-12-18123110575
  13. National Institute for Health and Care Excellence (NICE). Depression in Adults with a Chronic Physical Health Problem. Clinical Guidance [CG91]. London: NICE; 2009.
  14. McManus S, Meltzer H, Brugha T, Bebbington P, Jenkins R. Adult Psychiatric Morbidity in England 2007: Results of a Household Survey. Leeds: NHS Digital; 2009.
  15. Dowrick C, Chew-Graham C, Lovell K, Lamb J, Aseem S, Beatty S, et al. Increasing equity of access to high-quality mental health services in primary care: a mixed-methods study. Programme Grants Appl Res 2013;1(2). 10.3310/pgfar01020
  16. Pharmaceutical Services Negotiating Committee. About Community Pharmacy. URL: https://psnc.org.uk/psncs-work/about-community-pharmacy/ (accessed 30 October 2019).
  17. Todd A, Copeland A, Husband A, Kasim A, Bambra C. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 2014;4:e005764. 10.1136/bmjopen-2014-005764
  18. Todd A, Copeland A, Husband A, Kasim A, Bambra C. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open 2015;5:e007328. 10.1136/bmjopen-2014-007328
  19. Lindsey L, Husband A, Steed L, Walton R, Todd A. Helpful advice and hidden expertize: pharmacy users’ experiences of community pharmacy accessibility. J Public Health 2017;39:609–15. 10.1093/pubmed/fdw089
  20. Knox K, Kelly F, Mey A, Hattingh L, Fowler JL, Wheeler AJ. Australian mental health consumers’ and carers’ experiences of community pharmacy service. Health Expect 2015;18:2107–20. 10.1111/hex.1217924612376
  21. Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health 2011;11:582. 10.1186/1471-2458-11-58221777456
  22. Steed L, Kassavou K, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, et al. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes (Protocol). Cochrane Database Syst Rev 2014;7:CD011207. 10.1002/14651858.CD011207
  23. Pharmaceutical Services Negotiating Committee. PSNC Briefing 026/19: A Summary of the Five-Year Deal on the Community Pharmacy Contractual Framework. URL: https://psnc.org.uk/wp-content/uploads/2019/07/PSNC-Briefing-026.19-A-Summary-of-the-Five-Year-Deal-on-the-Community-Pharmacy-Contractual-Framework.pdf (accessed 30 October 2019).
  24. Department of Health and Social Care, NHS England and NHS Improvement, Pharmaceutical Services Negotiating Committee. The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: Supporting Delivery for the NHS Long Term Plan. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/819601/cpcf-2019-to-2024.pdf (accessed 3 February 2020).
  25. Pharmaceutical Services Negotiating Committee. PSNC Healthy Living Pharmacies. URL: https://psnc.org.uk/services-commissioning/locally-commissioned-services/healthy-living-pharmacies/ (accessed 30 October 2019).
  26. Thomson K, Hillier-Brown F, Walton N, Bilaj M, Bambra C, Todd A. The effects of community pharmacy-delivered public health interventions on population health and health inequalities: a review of reviews. Prev Med 2019;124:98–109. 10.1016/j.ypmed.2019.04.00330959070
  27. Patel C, North F, Head J, et al. The Marmot Review. Fair Society, Healthy Lives: Strategic Review of Health Inequalities in England Post-2010. London: University College London; 2010.
  28. NHS Confederation. Health on the High Street: Rethinking the Role of Community Pharmacy. London: NHS Confederation; 2013.
  29. Smith SM, Wallace E, O’Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev 2016;3:CD006560. 10.1002/14651858.CD006560.pub3
  30. van Zoonen K, Buntrock C, Ebert DD, Smit F, Reynolds CF, Beekman AT, Cuijpers P. Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol 2014;43:318–29. 10.1093/ije/dyt17524760873
  31. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998;1:2.10345255
  32. Gunn J, Diggens J, Hegarty K, Blashki G. A systematic review of complex system interventions designed to increase recovery from depression in primary car. BMC Health Serv Res 2006;6:88. 10.1186/1472-6963-6-8816842629
  33. Gilbody S, Bower P, Fletcher J, Richards D, Sutton A. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006;166:2314–21. 10.1001/archinte.166.21.231417130383
  34. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA 2003;289:3145–51. 10.1001/jama.289.23.314512813120
  35. Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev 2012;10:CD006525. 10.1002/14651858.CD006525.pub2
  36. Ekers D, Murphy R, Archer J, Ebenezer C, Kemp D, Gilbody S. Nurse-delivered collaborative care for depression and long-term physical conditions: a systematic review and meta-analysis. J Affect Disord 2013;149:14–22. 10.1016/j.jad.2013.02.03223545062
  37. Mitchell N, Hewitt C, Adamson J, Parrott S, Torgerson D, Ekers D, et al. A randomised evaluation of CollAborative care and active surveillance for Screen-Positive EldeRs with sub-threshold depression (CASPER): study protocol for a randomized controlled trial. Trials 2011;12:225. 10.1186/1745-6215-12-22521988800
  38. Gilbody S, Lewis H, Adamson J, Atherton K, Bailey D, Birtwistle J, et al. Effect of collaborative care vs usual care on depressive symptoms in older adults with subthreshold depression: the CASPER randomized clinical trial. JAMA 2017;317:728–37. 10.1001/jama.2017.013028241357
  39. Kingstone T, Bartlam B, Burroughs H, Bullock P, Lovell K, Ray M, et al. Can support workers from AgeUK deliver an intervention to support older people with anxiety and depression? A qualitative evaluation. BMC Fam Pract 2019;20:16. 10.1186/s12875-019-0903-130660195
  40. Kingstone T, Burroughs H, Bartlam B, Ray M, Proctor J, Shepherd T, et al. Developing a community-based psycho-social intervention with older people and third sector workers for anxiety and depression: a qualitative study. BMC Fam Pract 2017;18:77. 10.1186/s12875-017-0648-728701184
  41. Gilbody S, Bower P, Whitty P. Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry 2006;189:297–308. 10.1192/bjp.bp.105.01600617012652
  42. Sampson SJ, Todd A, Walton N, Steele R, Webster L, Churchill R, et al. Pharmacy based management for depression in adults. Cochrane Database Syst Rev 2019;4:CD013299. 10.1002/14651858.CD013299
  43. Brown JVE, Walton N, Meader N, Todd A, Webster LA, Steele R, et al. Pharmacy-based management for depression in adults. Cochrane Database Syst Rev 2019;12:CD013299. 10.1002/14651858.CD013299.pub2
  44. Littlewood E, Ali S, Badenhorst J, Bailey D, Bambra C, Chew-Graham C, et al. Community Pharmacies Mood Intervention Study (CHEMIST): feasibility and external pilot randomised controlled trial protocol. Pilot Feasibility Stud 2019;5:71. 10.1186/s40814-019-0457-y31161045
  45. May C, Finch T. Implementing, embedding, and integrating practices: an outline of normalization process theory. Sociology 2009;43:535–54. 10.1177/0038038509103208
  46. Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. London: Routledge; 1994. pp. 173–94. 10.4324/9780203413081_chapter_9
  47. Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017;17:88. 10.1186/s12913-017-2031-828126032
  48. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):22–33.
  49. Department of Health and Social Care. Improving the Health and Well-being of People with Long-term Conditions. World Class Services for People with Long-term Conditions – Information Tool for Commissioners. London: Department of Health and Social Care; 2010.
  50. NHS England. 2019/20 General Medical Services (GMS) Contract Quality and Outcomes Framework (QOF). London: NHS England; 2019.
  51. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997;12:439–45. 10.1046/j.1525-1497.1997.00076.x9229283
  52. National Institute for Care Excellence (NICE). Management of Depression in Primary and Secondary Care. London: NICE; 2009.
  53. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders (4th edition, text revision). Washington, DC: APA; 2000.
  54. World Health Organization (WHO). ICD-10: International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. 2nd edn. Geneva: WHO; 2004.
  55. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687. 10.1136/bmj.g168724609605
  56. Overend K, Lewis H, Bailey D, Bosanquet K, Chew-Graham C, Ekers D, et al. CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial. Trials 2014;15:451. 10.1186/1745-6215-15-45125409776
  57. Martell CR, Dimidjian S, Herman-Dunn R. Behavioral Activation for Depression: A Clinician’s Guide. New York, NY: Guilford Press; 2013.
  58. Pasterfield M, Bailey D, Hems D, McMillan D, Richards D, Gilbody S. Adapting manualized behavioural activation treatment for older adults with depression. Cogn Behav Ther 2014;7:E5. 10.1017/S1754470X14000038
  59. Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005;44:227–39. 10.1348/014466505X2965716004657
  60. Page AC, Hooke GR, Morrison DL. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in depressed clinical samples. Br J Clin Psychol 2007;46:283–97. 10.1348/014466506X15899617697478
  61. Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, et al. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive–compulsive disorder: the Obsessive–Compulsive Treatment Efficacy randomised controlled Trial (OCTET). Health Technol Assess 2017;21(37). 10.3310/hta21370
  62. Manos RC, Kanter JW, Luo W. The behavioral activation for depression scale–short form: development and validation. Behav Ther 2011;42:726–39. 10.1016/j.beth.2011.04.00422036000
  63. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13. 10.1046/j.1525-1497.2001.016009606.x11556941
  64. Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract 2007;57:650–2.17688760
  65. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092–7. 10.1001/archinte.166.10.109216717171
  66. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–66. 10.1097/00006842-200203000-0000811914441
  67. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33. 10.1097/00005650-199603000-000038628042
  68. EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208. 10.1016/0168-8510(90)90421-910109801
  69. Glaser BG. The constant comparative method of qualitative analysis. Soc Probl 1965;12:436–45. 10.2307/798843
  70. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015;350:h1258. 10.1136/bmj.h125825791983
  71. Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D, Brazier J. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry 2014;205:236–43. 10.1192/bjp.bp.112.12228324855127
  72. Byford S, Harrington R, Torgerson D, Kerfoot M, Dyer E, Harrington V, et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves. Results of a randomised controlled trial. Br J Psychiatry 1999;174:56–62. 10.1192/bjp.174.1.5610211152
  73. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108. 10.1097/00005650-199711000-000029366889
  74. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42:851–9. 10.1097/01.mlr.0000135827.18610.0d15319610
  75. Chew-Graham CA, Kitchen CEW, Gascoyne S, Littlewood E, Coleman E, Bailey D, et al. The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation – the Community Pharmacies Mood Intervention Study (CHEMIST). Pilot Feasibility Stud 2022;8:27. 10.1186/s40814-022-00992-735115052
  76. Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, et al. Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ 2013;347:f4913. 10.1136/bmj.f491323959152
  77. Murray E, Treweek S, Pope C, MacFarlane A, Ballini L, Dowrick C, et al. Normalisation process theory: a framework for developing, evaluating and implementing complex interventions. BMC Med 2010;8:63. 10.1186/1741-7015-8-6320961442
  78. Kraemer H, Wilson G, Fairburn CG, Agras W. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877–83. 10.1001/archpsyc.59.10.87712365874
  79. Department of Health and Social Care (DHSC). NHS Reference Costs 2017/18. URL: https://improvement.nhs.uk/resources/reference-costs/ (accessed 30 October 2019).
  80. Curtis L, Burns A. Unit Costs of Health and Social Care 2017. Canterbury: Personal Social Services Research Unit, University of Kent; 2017.
  81. May C, Rapley T, Mair FS, Treweek S, Murray E, Ballini L, et al. Normalization Process Theory On-Line Users’ Manual, Toolkit and Nomad Instrument. URL: www normalizationprocess.org (accessed 27 August 2020).
  82. May CR, Cummings A, Girling M, Bracher M, Mair FS, May CM, et al. Using normalization process theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implement Sci 2018;13:80. 10.1186/s13012-018-0758-129879986
  83. NHS. Pay Rates in Local Government. URL: www.healthcareers.nhs.uk/working-health/working-public-health/employers-public-health-staff/local-government/pay-rates-local-government (accessed 2 February 2020).
  84. University of York. Grades 1–8R. URL: www.york.ac.uk/admin/hr/pay-and-grading/pay-scales/grades-1-8/ (accessed 2 February 2020).
  85. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96. 10.1002/hec.94415497198
  86. Community and Mental Health team, NHS Digital. Psychological Therapies: Annual Report on the Use of IAPT Services, England 2018–19. 2019. URL: https://files.digital.nhs.uk/1C/538E29/psych-ther-2018-19-ann-rep.pdf (accessed 3 February 2020).
  87. The Pharmaceutical Journal. Pharmacy Funding Cuts: The Story so Far. URL: www.pharmaceutical-journal.com/news-and-analysis/features/pharmacy-funding-cuts-the-story-so-far/20202223.article?firstPass=false (accessed 3 February 2020).
  88. Kennedy B. Everything You Need to Know About the Pharmacy Cuts. URL: www.chemistanddruggist.co.uk/feature/everything-you-wanted-know-about-funding-cuts (accessed 3 February 2020).
  89. Popp L, Schneider S. Attention placebo control in randomized controlled trials of psychosocial interventions: theory and practice. Trials 2015;16:150. 10.1186/s13063-015-0679-025872619
← Discussion and conclusionsAcknowledgements →

Attribution. Elizabeth Littlewood; Carolyn A Chew-Graham; Elizabeth Coleman; Samantha Gascoyne; Claire Sloan; Shehzad Ali et al. (2022). A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: the CHEMIST pilot RCT. NIHR Journals Library. Copyright © Queen’s Printer and Controller of HMSO 2022. This work was produced by Littlewood et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Licensed under CC BY 4.0. NCBI Bookshelf NBK579121. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support